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INTRODUCTION
At the recent annual meeting of the Internatioflal Hepatobiliary and Pancreatic
Association in Hong Kong the following panel was assembled with the aims of
discussing the efficacy of the various methods of treatment available for patients
with symptomatic gallstones. The panel comprised Drs S.K. Lam, G. Stevenson,
T.K. Choi, G. Berci, E. Mack and F. Moody and it was Chaired by J. Toouli.
INCIDENCE AND SYMPTOMS
Gallstones occur commonly in Western countries. It has been estimated that during
normal life expectancy, 22% of men and 33% of women have gallstones, and that
in 50% of cases these are symptomatic1. In the United States, for example, some 15
million people may have gallstones, the stones becoming symptomatic in some
three million cases between the ages of 55-60 years. Half a million cholecystecto-
mies are performed yearly to treat gallstones. The stones usually in Western
patients are normally cholesterol stones or mixed stones. Black pigment stones
occur less frequently. In Asia, cholesterol stones are much less common, and the
predominant types are brown pigment and mixed stones. Brown pigment stones are
amorphous, soft, and muddy, and thus tend to break up readily; an important
feature when lithotripsy is being considered as a form of therapy. The male to
female ratio of Chinese patients with gallstones is about 2 to 1 as opposed to the
ratio of 1 to 3 generally seen in Western countries.
The major symptom produced by gallstones is pain. Dyspepsia, flatulence or
nausea are symptoms which are not specific to gallstones. Available data indicate
that treatment of gallstones should only be considered once symptoms develop2’3.
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In patients with asymptomatic gallstones, only approximately 10-20% eventually
develop symptoms.
INVESTIGATION
Ultrasonography is the initial investigation used when cholelithiasis is suspected4, it
has a sensitivity and specificity which are both between 94-98%. Unlike oral
cholecystography, which has comparable reliability, ultrasonography avoids expo-
sure to radiation. Cholecystography should be used only when doubt remains after
ultrasonography. Ultrasonography is useful in the diagnosis of acute cholecystitis in
that oedema of the gallbladder wall may be detected. However, the sensitivity and
specificity of this sign has yet to be precisely determined. If there is doubt about the
diagnosis of cholecystitis, scintigraphy is used to determine cystic duct patency. An
obstructed cystic duct supports the diagnosis of acute cholecystitis.
In patients being evaluated for extracorporeal shock wave lithotripsy (ESWL) or
dissolution therapy the oral cholecystogram is used to determine cystic duct
patency and size of the gallstones. CT scan evaluation of the gallstones has been
used recently to detect rings of calcium in the stone5. Such stones are resistant to
treatment by ESWL or dissolution.
Following pancreatitis ultrasonography is the most appropriate investigation to
detect gallbladder stones. However, to determine whether stones are present in the
bile duct, endoscopic cholangio pancreatography (ERCP) is the most accurate
investigation. Ultrasonography has a low sensitivity for detecting stones in the bile
duct.
CHOLECYSTECTOMY
Cholecystectomy remains the "gold standard" for the treatment of gallstones. It has
an operative mortality of less than 0.2%, a low morbidity and the majority of
patients are cured of their disease6. A small percentage of patients may develop
post-cholecystectomy biliary problems due to persistant or recurrent stone disease,
iatrogenic injury or motility disorders affecting the sphincter of Oddi.
Once stones have passed from the gallbladder into the bile duct the treatment
options depend on the patients age and the presence of associated medical
conditions. In patients without a gallbladder the preferred treatment for gallstones
in the bile duct is endoscopic sphincterotomy with extraction of the stones by a
basket or balloon catheter. In patients with a gallbladder, choledochotomy at the
time of cholecystectomy is a safe procedure with low morbidity8. However in
elderly or infirm patients, endoscopic sphincterectomy is recommended to extract
the bile duct stones leaving the gallbladder in situ. The overall incidence of
problems arising from the retained gallbladder is approximately 15%; if the cystic
duct is obstructed this incidence rises to around 50%
LAPAROSCOPIC CHOLECYSTECTOMY
Laparoscopic Cholecystectomy has created great interest since its recent introduc-
tion. Series with large numbers of patients are being reported from France1, theSYMPTOMATIC GALLSTONES 257
USA11 and Britain12. What is intriguing is the fact that patients are ambulant on the
day after the procedure, with rapid discharge from hospital and a return to normal
activity, including work, within a week. On initial assessment there appear to be
enormous advantages in carrying out cholecystectomy by laparoscopic means.
Morbidity and mortality appear to be similar to that of open cholecystectomy1.
The principles of the operation are identical to those for open surgery and
precautions to avoid iatrogenic injury need to be observed meticulously. As with
any new procedure, training is vital for surgeons embarking on this type of surgery.
In the opinion of many hepatobiliary surgeons, the laparoscopic approach to the
biliary tract will revolutionize surgery of the biliary tract. It .is estimated that
approximately 70% of patients with symptomatic gallstones can be treated in this
way12. It is recommended at this stage that patients with acute cholecystitis should
still be treated by open cholecystectomy. Similarly, patients who have previously
undergone surgery to the upper abdomen should be excluded as adhesions may
make laparoscopy hazardous. However future developments in laparoscopic tech-
niques may reduce some of the contraindications and allow treatment of more
patients with symptomatic gallstones.
DISSOLUTION OF GALLSTONES
A variety of agents have been used to dissolve gallstones. The attraction of these
agents for patients with symptomatic gallstones and their clinicians is the possibility
of treating the stones without major intervention. However the fact that the
gallbladder remains is often associated with significant recurrence of the gallstones
and the need for repeated treatment.
Agents for oral dissolution include ursodiol (ursodeoxycholic acid, UDCA),
chenodiol (chenodeoxycholic acid CDCA) and terpenes (mainly menthol). These
agents can be used alone or as adjuvant therapy. They can only be used for the
treatment of radiolucent cholesterol gallstones and require the presence of a patent
cystic duct. CDCA acts by expanding the bile acid pool and inhibits cholesterol
synthesis and secretion. Diarrhoea, which is dose related, affects approximately
50% of patients. CDCA leads to an increase in serum cholesterol as well as
transient increase in serum amino transferases. The dose of CDCA is 15mg/kg/day
and the efficacy of dissolution is approximately 30-40% 13. The duration of oral bile
acid therapy for dissolution is 1-2 years and the cost is approximately $US1.00/day.
UDCA acts by inhibiting cholesterol secretion in bile and reduces gut cholesterol
absorption. It promotes non-micellar mechanisms of cholesterol solubilization and
has practically no side effects. The dosage of UDCA is 10mg/kg/day and the
efficacy of dissolution for cholesterol gallstones is 50-80%. Duration of therapy is
approximately 1-2 years and the cost of the medication is $US3-4.00/day13.
Contact solvents used to dissolve cholesterol gallstones include mono-octanoin,
methyltert-butyl ether (MTBE), D-limonene, GS-100, and EDTA. Mono-octanoin
has been used more extensively, mainly for dissolving stones in the bile duct. Side
effects include nausea, vomiting, pain and diarrhoea. The efficacy for dissolution of
bile duct stones is 50-80% following continuous infusion into the bile duct for up to
1 week.
MTBE is an experimental agent which is mainly employed for cholesterol stones
within the gallbladder. It is explosive and malodorous and it causes nausea and
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dissolution is 1-3 days and efficacy is 90-100%. EDTA-bile acid mixtures have
been used experimentally for brown pigment stones. The disadvantages are again a
slow dissolution rate and an adjuvant agent or technique is needed for successful
outcomeTM.
The major disadvantage of all dissolution agents is the recurrence rate which for
CDCA and UDCA is recorded at 50% at 5 years. However in patients deemed to
be at major risk following more invasive procedures, dissolution therapy provides a
minimally invasive avenue for therapy. The indications to use mono-octanoin to
treat bile duct stones have diminished with the availability of endoscopic and
percutaneous methods of stone extraction. However occasionally it may be used as
an adjuvant to the extraction technique in order to soften or reduce the size of a
large stone so that it might more easily be removed15.
EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY
Non interventional treatment of gallstones appeared to become reality with the first
reports of extracorporeal shock wave lithotripsy (ESWL) in the treatment of
symptomatic gallstones16. Results from a trial conducted in Munich using a water
bath spark-gap acoustic generator reported efficacy of approximately 90% in
appropriate patients maintained on chenodiol and ursodiol for one year after
lithotripsy. On the basis of this experience trials were initiated using three types of
acoustical wave generators; spark-gap, electromagnetic and piezo electric. The
spark gap generator has a broader acoustical focus at the level of the target zone
and therefore has a greater success at shattering the stones. However it requires
analgesia and sedation during treatments. The electromagnetic and piezo electric
machines offer relatively pain-free treatment but multiple treatments because of
their small focal zone. All of the techniques require adjuvant bile salt therapy for
approximately one year to obtain stone clearance.
Experience in subsequent trials, conducted mainly in the USA have provided the
following principles. ESWL is safe and well tolerated. Selection and targetting are
essential for success. The fragmentation rate is approximately 90% in patients with
non-calcified stones. Approximately 40% of patients have biliary colic in the early
weeks after treatment. Thirty per cent will have stone fragments of a size that will
benefit from retreatment. Approximately 10% of patients require cholecystectomy
for continuing symptoms and all patients require bile salt therapy to achieve stone
clearance. The overall success rate for stone clearance at 6 months is between 42
and 69%, but this may improve up to 90% at one year 19. A major drawback is the
recurrence rate after successful dissolution. Early reports suggest a recurrence rate
of stones of approximately 10% per year and is similar to the recurrence rate
reported after either UDCA or CDCA therapy21.
RECOMMENDATIONS
The panel concluded that symptomatic gallstones, as opposed to asymptomatic
stones, warrant treatment. The initial investigation to demonstrate gallstones is
ultrasonography and in the majority of patients, this investigation suffices prior toSYMPTOMATIC GALLSTONES 259
treatment. Cholecystectomy is the most efficacious therapy for symptomatic gall-
stones in most patients. With the evolution of laparoscopic cholecystectomy and its
attributes, this technique is poised to become the gold standard for the treatment of
gallstones. In patients with stones in the bile duct presenting some time after
cholecystectomy and demonstrated by ERCP, extraction after endoscopic sphinc-
terotomy provides the best approach. All other techniques for the management of
gallstones are either inferior to the above or are experimental and recommended
only for specific clinical situations which do not allow the use of the above
techniques. Dissolution therapy using oral agents or contact solutions are confined
to patients with medical disorders which make the above procedures hazardous.
ESWL is used as an aid to dissolution. However its overall efficacy requires further
study. The major drawback for both dissolution and ESWL is the high recurrence
of gallstones whereas cholecystectomy by laparoscopic means or open surgery deals
with the diseased gallbladder permanently.
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